{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T11:32:04Z","timestamp":1774611124114,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,9,16]],"date-time":"2017-09-16T00:00:00Z","timestamp":1505520000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00520-017-3897-z","type":"journal-article","created":{"date-parts":[[2017,9,16]],"date-time":"2017-09-16T20:48:23Z","timestamp":1505594903000},"page":"833-841","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Symptom experience of multiple myeloma (syMMex) patients treated with autologous stem cell transplantation following high-dose melphalan: a descriptive longitudinal study"],"prefix":"10.1007","volume":"26","author":[{"given":"Matthias","family":"Naegele","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Kirsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Ihorst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Fierz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Engelhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabina","family":"De Geest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,16]]},"reference":[{"issue":"Suppl 6","key":"3897_CR1","doi-asserted-by":"crossref","first-page":"vi133","DOI":"10.1093\/annonc\/mdt297","volume":"24","author":"P Moreau","year":"2013","unstructured":"Moreau P et al (2013) Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 24(Suppl 6):vi133\u2013vi137","journal-title":"Ann Oncol"},{"key":"3897_CR2","unstructured":"Deutsches Register f\u00fcr Stammzelltransplantationen. Jahresbericht 2011. 2011 14.11.2011]; Available from: http:\/\/www.drst.de\/download\/jb2010.pdf"},{"issue":"23","key":"3897_CR3","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1182\/blood-2011-02-297325","volume":"117","author":"M Cavo","year":"2011","unstructured":"Cavo M et al (2011) International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation. Blood 117(23):6063\u20136073","journal-title":"Blood"},{"issue":"8","key":"3897_CR4","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.3109\/10428194.2010.487959","volume":"51","author":"M Engelhardt","year":"2010","unstructured":"Engelhardt M et al (2010) Consensus statement from European experts on the diagnosis, management, and treatment of multiple myeloma: from standard therapy to novel approaches. Leuk Lymphoma 51(8):1424\u20131443","journal-title":"Leuk Lymphoma"},{"issue":"25","key":"3897_CR5","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1056\/NEJMct0805626","volume":"360","author":"JL Harousseau","year":"2009","unstructured":"Harousseau JL, Moreau P (2009) Autologous hematopoietic stem-cell transplantation for multiple myeloma. N Engl J Med 360(25):2645\u20132654","journal-title":"N Engl J Med"},{"issue":"12","key":"3897_CR6","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/sj.bmt.1705664","volume":"39","author":"KO Anderson","year":"2007","unstructured":"Anderson KO et al (2007) Symptom burden in patients undergoing autologous stem-cell transplantation. Bone Marrow Transplant 39(12):759\u2013766","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"3897_CR7","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1002\/cncr.23299","volume":"112","author":"E Campagnaro","year":"2008","unstructured":"Campagnaro E et al (2008) Symptom burden after autologous stem cell transplantation for multiple myeloma. Cancer 112(7):1617\u20131624","journal-title":"Cancer"},{"issue":"1","key":"3897_CR8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1365-2354.2003.00315.x","volume":"12","author":"J Larsen","year":"2003","unstructured":"Larsen J et al (2003) Symptom distress, functional status and health-related quality of life before high-dose chemotherapy with stem-cell transplantation. Eur J Cancer Care 12(1):71\u201380","journal-title":"Eur J Cancer Care"},{"issue":"1","key":"3897_CR9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00002820-200401000-00007","volume":"27","author":"J Larsen","year":"2004","unstructured":"Larsen J et al (2004) Symptom occurrence, symptom intensity, and symptom distress in patients undergoing high-dose chemotherapy with stem-cell transplantation. Cancer Nurs 27(1):55","journal-title":"Cancer Nurs"},{"issue":"7","key":"3897_CR10","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00520-006-0200-0","volume":"15","author":"J Larsen","year":"2007","unstructured":"Larsen J et al (2007) Factors associated with poor general health after stem-cell transplantation. Support Care Cancer 15(7):849\u2013857","journal-title":"Support Care Cancer"},{"issue":"2","key":"3897_CR11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/02841860701558799","volume":"47","author":"I Andersson","year":"2008","unstructured":"Andersson I et al (2008) Health related quality of life in stem cell transplantation: clinical and psychometric validation of the questionnaire module, high dose chemotherapy (HDC-19). Acta Oncol 47(2):275\u2013285","journal-title":"Acta Oncol"},{"issue":"1","key":"3897_CR12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1385\/MO:18:1:65","volume":"18","author":"N Gulbrandsen","year":"2001","unstructured":"Gulbrandsen N et al (2001) Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell support. Med Oncol 18(1):65\u201377","journal-title":"Med Oncol"},{"issue":"9","key":"3897_CR13","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s00520-003-0464-6","volume":"11","author":"AC Sherman","year":"2003","unstructured":"Sherman AC et al (2003) Use of a supportive care team for screening and preemptive intervention among multiple myeloma patients receiving stem cell transplantation. Support Care Cancer 11(9):568\u2013574","journal-title":"Support Care Cancer"},{"issue":"8","key":"3897_CR14","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/sj.bmt.1704646","volume":"34","author":"M Diez-Campelo","year":"2004","unstructured":"Diez-Campelo M et al (2004) Quality of life assessment in patients undergoing reduced intensity conditioning allogeneic as compared to autologous transplantation: results of a prospective study. Bone Marrow Transplant 34(8):729\u2013738","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"3897_CR15","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/sj.bmt.1704465","volume":"33","author":"AC Sherman","year":"2004","unstructured":"Sherman AC et al (2004) Psychosocial adjustment and quality of life among multiple myeloma patients undergoing evaluation for autologous stem cell transplantation. Bone Marrow Transplant 33(9):955\u2013962","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"3897_CR16","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1600-0609.2004.00346.x","volume":"74","author":"CA Uyl-de Groot","year":"2005","unstructured":"Uyl-de Groot CA et al (2005) Health related quality of life in patients with multiple myeloma undergoing a double transplantation. Eur J Haematol 74(2):136\u2013143","journal-title":"Eur J Haematol"},{"issue":"1","key":"3897_CR17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bbmt.2008.09.023","volume":"15","author":"AC Sherman","year":"2009","unstructured":"Sherman AC et al (2009) Changes in quality-of-life and psychosocial adjustment among multiple myeloma patients treated with high-dose melphalan and autologous stem cell transplantation. Biol Blood Marrow Transplant 15(1):12\u201320","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"3897_CR18","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1188\/03.ONF.601-606","volume":"30","author":"TS Armstrong","year":"2003","unstructured":"Armstrong TS (2003) Symptoms experience: a concept analysis. Oncol Nurs Forum 30(4):601\u2013606","journal-title":"Oncol Nurs Forum"},{"issue":"21","key":"3897_CR19","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1182\/blood.V124.21.1277.1277","volume":"124","author":"LA Williams","year":"2014","unstructured":"Williams LA et al (2014) Symptom burden of busulfan + melphalan versus melphalan alone for multiple myeloma. Blood 124(21):1277\u20131277","journal-title":"Blood"},{"issue":"2","key":"3897_CR20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jpainsymman.2011.08.011","volume":"44","author":"MZ Cohen","year":"2012","unstructured":"Cohen MZ et al (2012) Symptoms and quality of life in diverse patients undergoing hematopoietic stem cell transplantation. J Pain Symptom Manag 44(2):168\u2013180","journal-title":"J Pain Symptom Manag"},{"key":"3897_CR21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1756-8722-6-13","volume":"6","author":"D Jones","year":"2013","unstructured":"Jones D et al (2013) Validation of the M. D. Anderson Symptom Inventory multiple myeloma module. J Hematol Oncol 6:13","journal-title":"J Hematol Oncol"},{"issue":"5","key":"3897_CR22","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1158\/1078-0432.CCR-13-2442","volume":"20","author":"XS Wang","year":"2014","unstructured":"Wang XS et al (2014) Inflammatory markers and development of symptom burden in patients with multiple myeloma during autologous stem cell transplantation. Clin Cancer Res 20(5):1366\u20131374","journal-title":"Clin Cancer Res"},{"issue":"11","key":"3897_CR23","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S1470-2045(06)70910-X","volume":"7","author":"E Basch","year":"2006","unstructured":"Basch E et al (2006) Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. Lancet Oncol 7(11):903\u2013909","journal-title":"Lancet Oncol"},{"key":"3897_CR24","unstructured":"U.S. Department of Health and Human Services, National Institutes of Health, and N.C. Institute. Common Terminology Criteria for Adverse Events (CTCAE). 2010 04.12.2015]; Available from: http:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_4.03_2010-06-14_QuickReference_8.5x11.pdf"},{"key":"3897_CR25","volume-title":"Das Blaue Buch: Chemotherapie-Manual H\u00e4matologie und Onkologie","author":"D Berger","year":"2009","unstructured":"Berger D et al (2009) Das Blaue Buch: Chemotherapie-Manual H\u00e4matologie und Onkologie, 3rd edn. Springer, Berlin","edition":"3"},{"issue":"34","key":"3897_CR26","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.1200\/JCO.2007.11.2243","volume":"25","author":"E Basch","year":"2007","unstructured":"Basch E et al (2007) Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy. J Clin Oncol 25(34):5374\u20135380","journal-title":"J Clin Oncol"},{"issue":"23","key":"3897_CR27","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1093\/jnci\/djp386","volume":"101","author":"E Basch","year":"2009","unstructured":"Basch E et al (2009) Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes. J Natl Cancer Inst 101(23):1624\u20131632","journal-title":"J Natl Cancer Inst"},{"issue":"21","key":"3897_CR28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1182\/blood.V124.21.177.177","volume":"124","author":"S Knop","year":"2014","unstructured":"Knop S et al (2014) Response to lenalidomide, doxorubicin and dexamethasone (RAD) in newly diagnosed multiple myeloma is independent of cytogenetic risk and retained after double stem cell transplant. Blood 124(21):177\u2013177","journal-title":"Blood"},{"issue":"9983","key":"3897_CR29","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(14)60493-1","volume":"385","author":"C Rollig","year":"2015","unstructured":"Rollig C, Knop S, Bornhauser M (2015) Multiple myeloma. Lancet 385(9983):2197\u20132208","journal-title":"Lancet"},{"key":"3897_CR30","doi-asserted-by":"crossref","unstructured":"Engelhardt M et al (2016) Autotransplants in older multiple myeloma patients: hype or hope in the era of novel agents? Haematologica","DOI":"10.3324\/haematol.2016.154807"},{"issue":"11","key":"3897_CR31","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.3324\/haematol.2016.151860","volume":"101","author":"C Straka","year":"2016","unstructured":"Straka C et al (2016) Autotransplant with and without induction chemotherapy in older multiple myeloma patients: long-term outcome of a randomized trial. Haematologica 101(11):1398\u20131406","journal-title":"Haematologica"},{"issue":"15","key":"3897_CR32","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","volume":"23","author":"PR Greipp","year":"2005","unstructured":"Greipp PR et al (2005) International staging system for multiple myeloma. J Clin Oncol 23(15):3412\u20133420","journal-title":"J Clin Oncol"},{"key":"3897_CR33","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1002\/1097-0142(19840501)53:9<2002::AID-CNCR2820530933>3.0.CO;2-W","volume":"53","author":"V Mor","year":"1984","unstructured":"Mor V et al (1984) The Karnovsky Performance Status Scale. An examination of its reliability and validity in research setting. Cancer 53:2002\u20132007","journal-title":"Cancer"},{"issue":"10","key":"3897_CR34","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/sj.bmt.1702672","volume":"26","author":"B Svahn","year":"2000","unstructured":"Svahn B et al (2000) Is it safe to treat allogeneic stem cell transplant recipients at home during the pancytopenic phase? A pilot trial. Bone Marrow Transplant 26(10):1057\u20131060","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"3897_CR35","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejon.2014.07.007","volume":"19","author":"M Kirsch","year":"2015","unstructured":"Kirsch M et al (2015) Linguistic and content validation of a German-language PRO-CTCAE-based patient-reported outcomes instrument to evaluate the late effect symptom experience after allogeneic hematopoietic stem cell transplantation. Eur J Oncol Nurs 19(1):66\u201374","journal-title":"Eur J Oncol Nurs"},{"issue":"Suppl 5","key":"3897_CR36","doi-asserted-by":"crossref","first-page":"v155","DOI":"10.1093\/annonc\/mdq178","volume":"21","author":"J Harousseau","year":"2010","unstructured":"Harousseau J, Dreyling M (2010) Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21(Suppl 5):v155\u2013v157","journal-title":"Ann Oncol"},{"issue":"6","key":"3897_CR37","doi-asserted-by":"crossref","first-page":"E576","DOI":"10.1111\/ctr.12002","volume":"26","author":"DM Lanuza","year":"2012","unstructured":"Lanuza DM et al (2012) A longitudinal study of patients\u2019 symptoms before and during the first year after lung transplantation. Clin Transpl 26(6):E576\u2013E589","journal-title":"Clin Transpl"},{"issue":"1 Suppl","key":"3897_CR38","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.bbmt.2011.10.029","volume":"18","author":"HS Jim","year":"2012","unstructured":"Jim HS, Syrjala KL, Rizzo D (2012) Supportive care of hematopoietic cell transplant patients. Biol Blood Marrow Transplant 18(1 Suppl):S12\u2013S16","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"3897_CR39","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2141.2011.08574.x","volume":"154","author":"JA Snowden","year":"2011","unstructured":"Snowden JA et al (2011) Guidelines for supportive care in multiple myeloma 2011. Br J Haematol 154(1):76\u2013103","journal-title":"Br J Haematol"},{"issue":"1","key":"3897_CR40","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00520-012-1644-z","volume":"21","author":"RJ Gibson","year":"2013","unstructured":"Gibson RJ et al (2013) Systematic review of agents for the management of gastrointestinal mucositis in cancer patients. Support Care Cancer 21(1):313\u2013326","journal-title":"Support Care Cancer"},{"key":"3897_CR41","doi-asserted-by":"crossref","unstructured":"Terpos, E., et al., European Myeloma Network guidelines for the management of multiple myeloma-related complications. Haematologica, 2015. 100(10): p. 1254\u20131266","DOI":"10.3324\/haematol.2014.117176"},{"issue":"1","key":"3897_CR42","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00520-012-1562-0","volume":"21","author":"DE Peterson","year":"2013","unstructured":"Peterson DE et al (2013) Systematic review of oral cryotherapy for management of oral mucositis caused by cancer therapy. Support Care Cancer 21(1):327\u2013332","journal-title":"Support Care Cancer"},{"issue":"5","key":"3897_CR43","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1086\/225231","volume":"77","author":"D Phillips","year":"1972","unstructured":"Phillips D, Clancy K (1972) Some effects of \u201csocial desirability\u201d in survey studies. Am J Sociol 77(5):921\u2013940","journal-title":"Am J Sociol"},{"issue":"3","key":"3897_CR44","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ejon.2004.08.002","volume":"9","author":"M Stephens","year":"2005","unstructured":"Stephens M (2005) The lived experience post-autologous haematopoietic stem cell transplant (HSCT): a phenomenological study. Eur J Oncol Nurs 9(3):204\u2013215","journal-title":"Eur J Oncol Nurs"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-017-3897-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-017-3897-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-017-3897-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T20:01:12Z","timestamp":1602964872000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-017-3897-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,16]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["3897"],"URL":"https:\/\/doi.org\/10.1007\/s00520-017-3897-z","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,16]]}}}